PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPEO.L Regulatory News (APEO)

  • There is currently no data for APEO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Name

29 Apr 2024 16:53

RNS Number : 4706M
abrdn Private Equity Opp Trst plc
29 April 2024
 

abrdn Private Equity Opportunities Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

 

29 April 2024

 

Change of Name

The Board of abrdn Private Equity Opportunities Trust plc (the "Company") notes the press release made today by abrdn plc in respect of the completion of the sale of its European-headquartered Private Equity business including the Company's investment manager, abrdn Capital Partners LLP ("abrdn Capital Partners"), to Patria Investments Ltd ("Patria"), a global alternative asset manager (the "Transaction").

As announced at the Company's AGM on 27 March 2024, following an extensive due diligence process, the Board consented to the Transaction by waiving the "Manager Change of Control" provisions set out in the Company's investment management agreement with abrdn Capital Partners. 

The Company will continue to be managed by abrdn Capital Partners (which has been renamed Patria Capital Partners LLP), which is now an indirect subsidiary of Patria. 

With immediate effect:

· the Company's name will change to Patria Private Equity Trust plc;

· the Company's registered office will change to 16 Charlotte Square, Edinburgh, EH2 4DF;

· the Company secretary will change to GPMS Corporate Secretary Limited (an indirect subsidiary of Patria); and

· the Company's website will change to https://patriaprivateequitytrust.com/

The Company has requested that the FCA and the LSE update their records for the Company's new name and to apply a new ticker (PPET) as soon as practicable, which is expected to take effect on Wednesday, 1 May 2024.

Alan Devine, the Company's Chair, said:

"As I mentioned at the Company's AGM in March, the Board has undertaken extensive due diligence in respect of the Transaction. We are delighted that the Transaction is not going to result in any changes to: (i) the Company's management and administration services; (ii) the Company's investment management process; or (iii) the personnel managing and servicing the Company. 

The Company will now be known as Patria Private Equity Trust plc to align more closely to the Patria brand. This is an exciting period for the Company as we continue to rely upon the existing attributes of our Manager whilst also reaping the benefits of Patria's wider geographical reach and private equity experience thus enabling us to build upon the Company's growth and performance since its establishment in 2001.

The Board is excited for the next stage of the Company's journey, and what Patria's involvement will bring."

For further information, please contact:

Patria Private Equity Trust plc

 

Alan Devine (Chair)

 

 

via SEC Newgate

 

The Manager & Company Secretary

 

Alan Gauld (Lead Manager)

Paul Evitt (Company Secretary)

 

 

via SEC Newgate

via SEC Newgate

Dickson Minto Advisers

 

 

Douglas Armstrong

 

 

+44 (0)20 7649 6823

SEC Newgate

Sally Walton

 

 

+44 (0)20 3757 6872

apeot@secnewgate.co.uk

Notes:

About Patria Investments

Patria is a global alternative investment firm with over 35 years of history and, following completion of the Transaction, has combined assets under management of over $40 billion, and a global presence with offices in 12 cities across 4 continents. Further information is available at www.patria.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANILMATMTATBBI
Date   Source Headline
30th Apr 202410:48 amRNSDirector/PDMR Shareholding
29th Apr 20244:53 pmRNSChange of Name
17th Apr 20247:00 amRNSEstimated NAV at 31 March 2024
16th Apr 202410:26 amRNSDirector/PDMR Shareholding
15th Apr 20244:51 pmRNSUpdate from QuotedData
8th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20244:37 pmRNSQuarterly disclosure
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20243:50 pmRNSResult of AGM and Investment Manager Update
19th Mar 20247:00 amRNSEstimated NAV at 29 February 2024
13th Mar 20247:00 amRNSFirst Interim Dividend
11th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20242:07 pmEQSEdison issues update on abrdn Private Equity Opportunities Trust (APEO): Returns and buyback help narrow the discount
26th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSEstimated NAV at 31 January 2024
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSAnnual Financial Report
30th Jan 20241:13 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSShare Buyback Programme
17th Jan 20247:00 amRNSEstimated NAV at 31 December 2023
12th Jan 20247:00 amRNSNotice of Results
5th Jan 20249:03 amRNSQuarterly disclosure
19th Dec 20237:00 amRNSEstimated NAV at 30 November 2023
14th Dec 20231:14 pmRNSReplacement - Fourth Interim Dividend
13th Dec 20237:00 amRNSFourth Interim Dividend
15th Nov 20237:00 amRNSEstimate NAV at 31 October 2023
31st Oct 20232:32 pmRNSHolding(s) in Company
31st Oct 20232:31 pmRNSHolding(s) in Company
31st Oct 20232:30 pmRNSHolding(s) in Company
31st Oct 202310:36 amRNSDirector/PDMR Shareholding
25th Oct 202311:34 amEQSEdison issues update on abrdn Private Equity Opportunities Trust (APEO): Resilient NAV and stable balance sheet
18th Oct 20237:00 amRNSEstimated NAV at 30 September 2023
16th Oct 202311:09 amRNSStatement regarding Investment Manager
6th Oct 20234:16 pmRNSQuotedData's Weekly News & Interview
4th Oct 20239:08 amRNSQuarterly disclosure
25th Sep 20237:00 amRNSEstimate NAV at 31 August 2023
14th Sep 20237:00 amRNSThird Interim Dividend
12th Sep 20239:56 amRNSAnnual Overview from QuotedData
18th Aug 20234:11 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSEstimated NAV at 31 July 2023
1st Aug 20233:09 pmRNSDirector/PDMR Shareholding
18th Jul 202312:11 pmRNSEdison issues update on abrdn PEO Trust
17th Jul 20237:00 amRNSEstimated NAV at 30 June 2023
7th Jul 20237:00 amRNSDoc re. Half Yearly Report
5th Jul 20239:19 amRNSQuarterly disclosure
28th Jun 20239:16 amRNSHalf-year Report - Replacement
28th Jun 20237:00 amRNSHalf-year Report
20th Jun 20237:00 amRNSEstimated NAV at 31 May 2023
14th Jun 20237:00 amRNSSecond Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.